MTOR and graft versus host disease: Clinic studies have revealed similar importance for mTOR in skin wound healing, as evidenced by the development of skin ulcerations and chronic wounds following treatment with mTOR inhibitor, everolimus, to prevent graft rejection in graft-versus-host-disease (Law, 2005; Feldmeyer et al., 2012; Brown et al., 2014).